Psychedelic News

BlogAugust 15, 2023

COMPASS Pathways Financial Analysis: Road to Profitability

BlogAugust 7, 2023

Braxia Scientific Financial Report Analysis

BlogAugust 4, 2023

Psychedelics and SSRIs: What the Science Says

BlogAugust 2, 2023

Cybin Brings in Capital with Public Offering

BlogAugust 1, 2023

Psychedelic Access is Coming to California

BlogJuly 27, 2023

Treating Anorexia with Psychedelics

BlogJuly 25, 2023

Unleashing the Potential of Psychedelic Science with Kernel Flow

Health & ScienceJuly 21, 2023

The Truth About the Chemical Imbalance Theory

BusinessJuly 19, 2023

UC Berkeley Survey: Understanding Voter Attitudes Towards Psychedelic Legalization

Market ResearchJuly 18, 2023

Kentucky Turns to Ibogaine to Fight the Opioid Epidemic

BlogJune 28, 2023

Insurance Coverage for Psychedelic Treatment: Breaking Down the Costs and Access

BlogJune 22, 2023

What’s Next?— Predictions for What Happens After MDMA is Approved

BlogJune 15, 2023

Breaking Political Boundaries: The Surprising Political Consensus on Psychedelics

BlogJune 13, 2023

Exploring Intersections: A Comparative Analysis of the Psychedelic and Cannabis Industries

BlogJune 6, 2023

Tripping Around The World: The Global Legal Landscape of Psychedelics

BlogJune 2, 2023

Psychedelic Search Trends: Insights into the Rising Popularity and Geographic Preferences of Mind-Altering Experiences

BlogMay 31, 2023

BREAKING: Kentucky To Invest in Ibogaine Treatment for Addiction

BlogMarch 8, 2023

Apex Labs Pioneers Take-Home Psychedelic Treatment

BlogFebruary 15, 2023

Real Estate for Psychedelics

Market ResearchNovember 15, 2022

The Influence of Shamans on the Psychedelic Industry

Market ResearchNovember 14, 2022

Colorado Votes Yes on Psychedelics

Market ResearchNovember 11, 2022

Placebos in Psychedelic Studies

Market ResearchNovember 10, 2022

The Rise Of The Psilocybin Retail Market

Market ResearchNovember 4, 2022

Fluence Moves To Withdraw Trademark